Jim Corbett
Jim Corbett has held leadership roles across biotechnology, medical imaging, analytical instruments and in vitro diagnostics. His experience ranges from Fortune 100 companies to start-ups.
Corbett spent 11 years at PerkinElmer, most recently serving as Executive Vice President and President of Discovery & Analytical Solutions. His other roles included Senior Vice President of Human Health, Senior Vice President of Life Sciences Solutions and President of Diagnostics & Life Sciences.
Prior to PerkinElmer, Corbett was President of ViaCell, Inc. He previously co-founded CADx Systems, a company focused on the oncology market, where he served as Executive Vice President and Director with responsibility for worldwide sales and marketing, technical support and business development. Following the acquisition of CADx by iCAD, Inc. in 2004, he was named Chief Commercial Officer.
Corbett also spent 14 years at Abbott Laboratories in sales, marketing and general management roles. He holds a Bachelor of Science from the University of Massachusetts Amherst.
Contact info
- Website:
- https://emulatebio.com/
ArticleWhat will it take to trust human-relevant models in drug discovery?
Could organ-on-a-chip technology help identify drug failures before clinical trials? Jim Corbett of Emulate discusses the evidence needed to make human-relevant models reliable tools in drug discovery.